Action 603077 SICHUAN HEBANG BIOTECHNOLOGY CORPORATION LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Sichuan Hebang Biotechnology Corporation Limited

Actions

603077

CNE100001JM9

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 29/04/2024 		Varia. 5j. Varia. 1 janv.
2,15 CNY +4,88 % Graphique intraday de Sichuan Hebang Biotechnology Corporation Limited +0,94 % -8,90 %
19/04 Sichuan Hebang Biotechnology Corporation Limited annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
21/02 Le vice-président de Yapp Automotive Parts démissionne MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on January 25, 2024.
Yapp Automotive Parts Vice Chairman Resigns
Chinese provinces target modest 2024 growth after missing previous goals
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on December 15, 2023.
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.
Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback announced on December 15, 2023, has closed with 168,811,563 shares, representing 1.93% for CNY 389.79 million.
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on December 15, 2023.
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on October 19, 2023.
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.
Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback announced on October 19, 2023, has closed with 170,337,200 shares, representing 1.95% for CNY 399.89 million.
Avenira Limited announced that it has received AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation Limited
Sichuan Hebang Biotechnology Corporation Limited(SHSE:603077) dropped from Shanghai Stock Exchange 180 Value Index
Sichuan Hebang Biotechnology Corporation Limited(SHSE:603077) dropped from SSE 180 Index
Hebang Biotechnology to Buy 10.5% Stake in Australia-Listed Avenira For AU$2 Million
Avenira Limited announced that it expects to receive AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation Limited
Sichuan Salt Industry Corporation and Sichuan Salt Industry Group West Sichuan Co., Ltd. agreed to acquire 49% stake in Sichuan Shuncheng Salt Products Co., Ltd from Sichuan Hebang Biotechnology Corporation Limited for approximately CNY 150 million.
Chinese graduates hold off career dreams, take temporary government jobs
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 603077
  4. Actualités Sichuan Hebang Biotechnology Corporation Limited
  5. Autres langues